Ultrasound-Guided Esophageal Compression During Adult Mask Ventilation
1 other identifier
interventional
103
1 country
1
Brief Summary
A total of 103 elective surgery patients who met the inclusion criteria were selected. After screening for eligibility according to the inclusion and exclusion criteria and signing informed consent, they were randomly divided into two groups. Upon entering the operating room, routine ECG monitoring was initiated, and a peripheral vein was opened. Ultrasound was used to measure the baseline cross-sectional area (CSA) of the gastric antrum in the supine position. After general anesthesia induction, positive pressure ventilation was applied via face mask. Group A received no external compression, while Group B underwent esophageal compression under ultrasound guidance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 25, 2024
CompletedFirst Submitted
Initial submission to the registry
October 15, 2024
CompletedFirst Posted
Study publicly available on registry
November 14, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 24, 2026
April 1, 2026
12 months
October 15, 2024
April 21, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
The incidence of gastric distension
Defined as a significant increase in gastric antrum CSA with acoustic shadowing or the characteristic "comet-tail sign," or when the enlarged gastric antrum obstructs the surgical field
During anesthesia induction
Secondary Outcomes (8)
The positional relationship between the esophagus and trachea
Before anesthesia induction
Tidal volume
During anesthesia induction
Oxygen saturation
During anesthesia induction
Airway plateau
During anesthesia induction
The percentage of glottic opening (POGO) score
During tracheal intubation, immediately
- +3 more secondary outcomes
Study Arms (2)
Group A (Control Group)
NO INTERVENTIONNo esophageal compression is applied, and FMV is performed for 4 minutes.
Group B (Intervention Group)
EXPERIMENTALUltrasound-guided esophageal compression plus FMV: before the start of FMV, ultrasound is used to locate the esophagus, and pressure is applied to the esophagus at the cricoid level to collapse the esophageal lumen. Esophageal pressure is released just before tracheal intubation following 4 minutes of ventilation.
Interventions
Before the start of FMV, ultrasound is used to locate the esophagus, and pressure is applied to the esophagus at the cricoid level to collapse the esophageal lumen. Esophageal pressure is released just before tracheal intubation following 4 minutes of ventilation.
Eligibility Criteria
You may qualify if:
- Age 18 to 65 years
- American Society of Anesthesiologists (ASA) Physical Status Classification I-II.
- Body Mass Index (BMI) between 18 and 28 kg/m².
- Patients undergoing elective tracheal intubation for general anesthesia.
- Patients scheduled for laparoscopic surgery.
- Fasting for ≥8 hours and abstaining from liquids for ≥2 hours before surgery, with low risk of gastroesophageal regurgitation and aspiration.
You may not qualify if:
- Suspected difficult FMV (e.g., age \>55 years, BMI \>26 kg/m², edentulous, history of snoring, and long beard; presence of two or more factors).
- Pre-existing respiratory, pharyngeal, laryngeal, facial, or neck pathology.
- History of gastrointestinal surgery, gastroesophageal reflux disease (GERD), or high risk of aspiration.
- Severe cardiac, cerebral, pulmonary, hepatic, or renal diseases.
- Patients requiring non-invasive ventilation prior to surgery.
- Patients currently participating in other clinical trials or who refuse to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Liu Hanlead
Study Sites (1)
Nanjing First Hospital
Nanjing, Jiangsu, 210006, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director, Department of Anesthesia, Pain and Perioperative Medicine
Study Record Dates
First Submitted
October 15, 2024
First Posted
November 14, 2024
Study Start
September 25, 2024
Primary Completion
September 12, 2025
Study Completion
December 31, 2025
Last Updated
April 24, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share